Viz.ai and NICO Corp. Announce Collaboration to Speed Patient Recruitment in the ENRICH Study

NICO Corp. to install Viz Recruit, an AI based clinical trial enrollment platform at ENRICH sites to increase enrollment rates and reduce time to randomization in intracerebral hemorrhage (ICH). In ENRICH (Early MiNimally-invasive Removal of ICH), Viz RECRUIT will notify investigators immediately when a patient meets the eligibility criteria for enrollment. “The ENRICH trial and NICO technologies can potentially transform the way that ICH is treated and change treatment guidelines,” said Chris Mansi, Neurosurgeon and CEO of Viz.ai. For more information about the ENRICH trial or patient criteria, visit ClinicalTrials.gov or EnrichTrial.com. Learn about NICO technologies at NICOneuro.com; follow news updates on LinkedIn and view surgical/patient videos on YouTube at NICOneuroCorp.